Influence of pulmonary surfactant on in vitro bactericidal activities of amoxicillin, ceftazidime, and tobramycin
about
Anti-staphylococcal activity resulting from epithelial lining fluid (ELF) concentrations of amikacin inhale administered via the pulmonary drug delivery systemAntimicrobial and biophysical properties of surfactant supplemented with an antimicrobial peptide for treatment of bacterial pneumonia.Exogenous pulmonary surfactant as a vehicle for antimicrobials: assessment of surfactant-antibacterial interactions in vitro.In vitro evaluation of inhalable isoniazid-loaded surfactant liposomes as an adjunct therapy in pulmonary tuberculosis.Human Bile Reduces Antimicrobial Activity of Selected Antibiotics against Enterococcus faecalis and Escherichia coli In Vitro.Lung clearance of intratracheally instilled 99mTc-tobramycin using pulmonary surfactant as vehicleExogenous pulmonary surfactant as a drug delivering agent: influence of antibiotics on surfactant activity.Effect of pulmonary surfactant on antimicrobial activity in vitro.Pulmonary surfactant as vehicle for intratracheally instilled tobramycin in mice infected with Klebsiella pneumoniae.Influence of a pulmonary surfactant on the in vitro activity of tobramycin against Pseudomonas aeruginosaEvaluation of antitubercular drug-loaded surfactants as inhalable drug-delivery systems for pulmonary tuberculosis.The Antibacterial and Anti-inflammatory Activity of Chicken Cathelicidin-2 combined with Exogenous Surfactant for the Treatment of Cystic Fibrosis-Associated Pathogens.Seventy-five years of research on protein binding - do we ever understand?
P2860
Q28468292-AB009C3E-7093-4603-A43F-7E14CE6494C5Q35607838-6C7B0117-26F9-48B1-9358-363EACDA4156Q39589727-316075CA-2BD8-4C14-8373-CC4A0F5BDBD8Q39696700-C4F4CD97-9D6C-46F1-AD09-72DA012FA7C6Q40192418-11960D81-853C-4A74-8953-F06CA95EC160Q41911714-1C1D3BCE-AD76-40F8-87FF-C6544D1FA4BAQ41966523-7F07890B-69CC-4B83-A457-E5B6019F89FAQ42049487-33E97FBC-4630-448F-BA2C-507847E529F3Q42580581-648559C1-6EC3-44D2-A836-5857212F0B15Q42729296-23B9FD85-8C90-4C01-93BC-ED32C33CC513Q46630588-8EF90591-F920-4630-972B-2E67980120A4Q47104073-8983B564-F52B-4C60-B742-AB4339DCEDBEQ47381610-9618240A-36CA-44B1-BE26-F3F6C0F548EB
P2860
Influence of pulmonary surfactant on in vitro bactericidal activities of amoxicillin, ceftazidime, and tobramycin
description
1995 nî lūn-bûn
@nan
1995 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Influence of pulmonary surfact ...... n, ceftazidime, and tobramycin
@ast
Influence of pulmonary surfact ...... n, ceftazidime, and tobramycin
@en
type
label
Influence of pulmonary surfact ...... n, ceftazidime, and tobramycin
@ast
Influence of pulmonary surfact ...... n, ceftazidime, and tobramycin
@en
prefLabel
Influence of pulmonary surfact ...... n, ceftazidime, and tobramycin
@ast
Influence of pulmonary surfact ...... n, ceftazidime, and tobramycin
@en
P2093
P2860
P356
P1476
Influence of pulmonary surfact ...... n, ceftazidime, and tobramycin
@en
P2093
Kluytmans JA
Lachmann B
van 't Veen A
P2860
P304
P356
10.1128/AAC.39.2.329
P407
P577
1995-02-01T00:00:00Z